1. Brady, R.O. et al. Enzymatic defect in Fabry's disease. N. Engl. J. Med. 276, 1163–1167 ( 1967).
2. Desnick, R.J., Ioannou, Y.A. & Eng, C.M. in The Metabolic and Molecular Bases of Inherited Disease (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 2741–2784 (McGraw–Hill, New York, 1995).
3. Romeo, G. et al. Residual activity of α–galactosidase A in Fabry's disease. Biochem. Genet. 13, 615– 628 (1975).
4. Bishop, D.F., Grabowski, G.A. & Desnick, R.J. Fabry disease: An asymptomatic hemizygote with significant residual α–galactosidase A activity. Am. J. Hum. Genet. 33, 71A (1981).
5. Ishii, S., Kase, R., Sakuraba, H. & Suzuki, Y. Characterization of a mutant α–galactosidase gene product for the late–onset cardiac form of Fabry disease. Biochem. Biophys. Res. Comm. 197, 1585–1589 (1993).